Cochrane Abstracts
Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rectal 5-aminosalicylic Acid for Maintenance of Remission in Ulcerative Colitis: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436566/all/Rectal_5_aminosalicylic_acid_for_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review.
Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436566/all/Rectal_5_aminosalicylic_acid_for_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review. Accessed December 3, 2024.
Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis: Cochrane systematic review. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436566/all/Rectal_5_aminosalicylic_acid_for_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review
Rectal 5-aminosalicylic Acid for Maintenance of Remission in Ulcerative Colitis: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436566/all/Rectal_5_aminosalicylic_acid_for_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rectal 5-aminosalicylic acid for maintenance of remission in ulcerative colitis: Cochrane systematic review
ID - 436566
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436566/all/Rectal_5_aminosalicylic_acid_for_maintenance_of_remission_in_ulcerative_colitis:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
